L. Duffy

发表

In Vitro Activities of ABT-773 and Other Antimicrobials against Human Mycoplasmas

K. Waites, D. Crabb, L. Duffy, 2003, Antimicrobial Agents and Chemotherapy.

Clearance of Mycoplasma Pneumoniae Is Impaired in Mice with Established Allergic Airway Inflammation

D. Chaplin, J. Lai, T. Atkinson, 2007 .

Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp.

J. Glass, K. Waites, V. Paralanov, 2011, International journal of antimicrobial agents.

Genotypic characterization of Ureaplasma species by pulsed field gel electrophoresis.

K. Waites, S. Moser, L. Duffy, 2006, Journal of microbiological methods.

Midtrimester vaginal Mycoplasma genitalium in women with subsequent spontaneous preterm birth.

J. Schwebke, J. Hauth, R. Goldenberg, 2001, American journal of obstetrics and gynecology.

Evaluation of Commercial Molecular Diagnostic Methods for Detection and Determination of Macrolide Resistance in Mycoplasma pneumoniae

Maureen H Diaz, E. Brooks, K. Fowler, 2020, Journal of Clinical Microbiology.

Lung Pathology in Premature Infants with Ureaplasma urealyticum Infection

G. Cassell, R. Viscardi, L. Duffy, 2002, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

Emerging Macrolide Resistance in Mycoplasma pneumoniae in Children: Detection and Characterization of Resistant Isolates

J. Hagood, K. Waites, C. Makris, 2009, The Pediatric infectious disease journal.

Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp.

M. Kempf, D. Crabb, L. Duffy, 2000, The Journal of antimicrobial chemotherapy.

Elevated Cytokine and Chemokine Levels and Prolonged Pulmonary Airflow Resistance in a Murine Mycoplasma pneumoniaePneumonia Model: a Microbiologic, Histologic, Immunologic, and Respiratory Plethysmographic Profile

O. Ramilo, H. Jafri, K. Olsen, 2001, Infection and Immunity.

In Vitro Susceptibilities to and Bactericidal Activities of Garenoxacin (BMS-284756) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas

K. Waites, D. Crabb, L. Duffy, 2003, Antimicrobial Agents and Chemotherapy.

Mycoplasma pneumoniae-induced activation and cytokine production in rodent mast cells.

K. Hoek, T. Atkinson, G. Cassell, 2002, The Journal of allergy and clinical immunology.

Comparative In Vitro Susceptibilities of Human Mycoplasmas and Ureaplasmas to a New Investigational Ketolide, CEM-101

K. Waites, D. Crabb, L. Duffy, 2009, Antimicrobial Agents and Chemotherapy.

Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program

Steven D. Dallas, E. Brooks, K. Fowler, 2019, Journal of Clinical Microbiology.

in Hospitalized Children Epidemiology and Clinical Characteristics of Community-Acquired Pneumonia

M. Leinonen, K. Olsen, G. Mccracken, 2005 .

Diagnostic Utility and Clinical Significance of Naso- and Oropharyngeal Samples Used in a PCR Assay To Diagnose Mycoplasma pneumoniae Infection in Children with Community-Acquired Pneumonia

K. Olsen, G. Mccracken, I. Michelow, 2004, Journal of Clinical Microbiology.

Detection of Ureaplasma urealyticum by polymerase chain reaction in the urogenital tract of adults, in amniotic fluid, and in the respiratory tract of newborns.

J. Hentschel, A. Blanchard, G. Cassell, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A role for the Mycoplasma pneumoniae adhesin P1 in interleukin (IL)-4 synthesis and release from rodent mast cells.

K. Hoek, T. Atkinson, G. Cassell, 2005, Microbial pathogenesis.

Transplacental transfer of Azithromycin and its use for eradicating intra-amniotic ureaplasma infection in a primate model.

E. Acosta, K. Waites, P. Grigsby, 2014, The Journal of infectious diseases.

Maternal azithromycin therapy for Ureaplasma intraamniotic infection delays preterm delivery and reduces fetal lung injury in a primate model.

E. Acosta, K. Waites, T. Morgan, 2012, American journal of obstetrics and gynecology.

Ureaplasma parvum or Mycoplasma hominis as Sole Pathogens Cause Chorioamnionitis, Preterm Delivery, and Fetal Pneumonia in Rhesus Macaques

M. Axthelm, S. Witkin, K. Waites, 2009, Reproductive Sciences.

Delivery , and Fetal Pneumonia in Rhesus Macaques Ureaplasma parvum or Mycoplasma hominis as Sole Pathogens Cause Chorioamnionitis , Preterm

M. Axthelm, S. Witkin, K. Waites, 2008 .

Experimental primate model for Ureaplasma chorioamnionitis and preterm labor

M. Axthelm, S. Witkin, M. Gravett, 2001 .

Inhibition of message for FcεRI α chain blocks mast cell IL-4 production induced by co-culture with Mycoplasma pneumoniae

T. Atkinson, L. Duffy, Yuling Dai, 2008 .

Antimicrobial Susceptibility among Pathogens Collected from Hospitalized Patients in the United States and In Vitro Activity of Tigecycline, a New Glycylcycline Antimicrobial

K. Waites, M. Dowzicky, L. Duffy, 2006, Antimicrobial Agents and Chemotherapy.

Characterization of Ureaplasmas Isolated from Preterm Infants with and without Bronchopulmonary Dysplasia

R. Schelonka, K. Waites, R. Dimmitt, 2005, Journal of Clinical Microbiology.

Evaluation of the Etest for detection of tetracycline resistance in Mycoplasma hominis.

K. Waites, G. Cassell, D. Crabb, 1997, Diagnostic microbiology and infectious disease.

Use of the polymerase chain reaction for detection of Mycoplasma fermentans and Mycoplasma genitalium in the urogenital tract and amniotic fluid.

A. Blanchard, G. Cassell, L. Duffy, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Mycoplasma pneumoniae: a frequent cause of pneumonia among U.S. Marines in southern California.

G. Gray, S. Putnam, G. Cassell, 1997, Military medicine.

In Vitro Activities of Lefamulin and Other Antimicrobial Agents against Macrolide-Susceptible and Macrolide-Resistant Mycoplasma pneumoniae from the United States, Europe, and China

S. Paukner, K. Waites, J. Jensen, 2016, Antimicrobial Agents and Chemotherapy.

In Vitro Antibacterial Activity of AZD0914 against Human Mycoplasmas and Ureaplasmas

M. Huband, K. Waites, D. Crabb, 2015, Antimicrobial Agents and Chemotherapy.

In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391

K. Waites, G. Cassell, D. Crabb, 1991, Antimicrobial Agents and Chemotherapy.

Ureaplasma urealyticum pneumonia: experimental production and demonstration of age-related susceptibility

K. Waites, G. Cassell, P. Rudd, 1989, Infection and immunity.

Serum concentrations of erythromycin after intravenous infusion in preterm neonates treated for Ureaplasma urealyticum infection.

K. Waites, G. Cassell, L. Duffy, 1994, The Pediatric infectious disease journal.

Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children.

Kurt Olsen, Jaana Kauppila, M. Leinonen, 2004, Pediatrics.

In Vitro Activities of Omadacycline (PTK 0796) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas

K. Waites, Yang Liu, D. Crabb, 2016, Antimicrobial Agents and Chemotherapy.

Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas; Approved Guideline

A. Matlow, Steven D. Brown, D. Talkington, 2011 .

Critical Role of Macrophages and Their Activation via MyD88-NFκB Signaling in Lung Innate Immunity to Mycoplasma pneumoniae

D. Chaplin, N. Van Rooijen, D. C. Krause, 2010, PloS one.

Molecular Characterization of Mycoplasma pneumoniae Isolates in the United States from 2012 to 2018

Steven D. Dallas, E. Brooks, K. Fowler, 2020, Journal of Clinical Microbiology.

Comparison of the illumigene Mycoplasma DNA Amplification Assay and Culture for Detection of Mycoplasma pneumoniae

K. Waites, L. Duffy, A. Ratliff, 2014, Journal of Clinical Microbiology.

In Vitro Activities of Gepotidacin (GSK2140944) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas

K. Waites, Li Xiao, D. Crabb, 2017, Antimicrobial Agents and Chemotherapy.

Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvumstrains

J. Glass, S. Yooseph, J. Inman, 2012, BMC Microbiology.

Chromosomal Mutations Responsible for Fluoroquinolone Resistance in Ureaplasma Species in the United States

J. Glass, K. Waites, V. Paralanov, 2012, Antimicrobial Agents and Chemotherapy.

Extensive Horizontal Gene Transfer in Ureaplasmas from Humans Questions the Utility of Serotyping for Diagnostic Purposes

J. Glass, K. Waites, Yuying Chen, 2011, Journal of Clinical Microbiology.

Effects of Antenatal Colonization with Ureaplasma urealyticum on Pulmonary Disease in the Immature Baboon

B. Yoder, J. Coalson, G. Cassell, 2003, Pediatric Research.

Detection and Characterization of Human Ureaplasma Species and Serovars by Real-Time PCR

J. Glass, S. Yooseph, K. Waites, 2010, Journal of Clinical Microbiology.

Efficacy of clarithromycin against Mycoplasma pneumoniae.

K. Waites, G. Cassell, J. Drnec, 1991, The Journal of antimicrobial chemotherapy.

In Vitro Activities of Eravacycline and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas

S. Leal, K. Waites, Li Xiao, 2020, Antimicrobial Agents and Chemotherapy.

Standardized Methods and Quality Control Limits for Agar and Broth Microdilution Susceptibility Testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum

A. Matlow, Steven D. Brown, D. Talkington, 2012, Journal of Clinical Microbiology.

Rapid detection of tetM in Mycoplasma hominis and Ureaplasma urealyticum by PCR: tetM confers resistance to tetracycline but not necessarily to doxycycline.

K. Dybvig, A. Blanchard, G. Cassell, 1992, FEMS microbiology letters.

Fluoroquinolone Resistance in Ureaplasma parvum in the United States

J. Glass, R. Avery, K. Waites, 2006, Journal of Clinical Microbiology.

Comparative In Vitro Susceptibilities and Bactericidal Activities of Investigational Fluoroquinolone ABT-492 and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas

K. Waites, D. Crabb, L. Duffy, 2003, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics, Safety, and Biologic Effects of Azithromycin in Extremely Preterm Infants at Risk for Ureaplasma Colonization and Bronchopulmonary Dysplasia

D. Kaufman, K. Fairchild, K. Waites, 2011, Journal of clinical pharmacology.

Inhibitory and bactericidal activities of gemifloxacin and other antimicrobials against Mycoplasma pneumoniae.

K. Waites, D. Crabb, L. Duffy, 2003, International journal of antimicrobial agents.

Comparison of agar versus broth dilution techniques for determining antibiotic susceptibilities of Ureaplasma urealyticum.

K. Waites, J. Simecka, D. Crabb, 1991, Diagnostic microbiology and infectious disease.

In vitro comparison of agar and microbroth dilution methods for determination of MICs for Mycoplasma hominis.

K. Waites, D. Crabb, L. Duffy, 2005, Journal of microbiological methods.

Mycoplasmal infections of cerebrospinal fluid in newborn infants from a community hospital population

K. Waites, K. Nelson, G. Cassell, 1990, The Pediatric infectious disease journal.

Frequency of Ureaplasma Serovars in Respiratory Secretions of Preterm Infants at Risk for Bronchopulmonary Dysplasia

K. Waites, R. Viscardi, Li Xiao, 2011, The Pediatric infectious disease journal.

Protein antigens of genital mycoplasmas.

G. Cassell, L. Duffy, H. Watson, 1988, Reviews of infectious diseases.

Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strains

J. Glass, S. Yooseph, J. Inman, 2012, BMC Microbiology.

Genotypic Characterization of Ureaplasma Serovars from Clinical Isolates by Pulsed-Field Gel Electrophoresis

J. Glass, K. Waites, S. Moser, 2011, Journal of Clinical Microbiology.

Detection of Human Mycoplasmas and Ureaplasmas from Clinical Specimens by Culture and PCR

K. Waites, Li Xiao, L. Duffy, 2016 .

Isolation of Ureaplasma urealyticum from low birth weight infants.

K. Waites, G. Cassell, L. Duffy, 1995, The Journal of pediatrics.

The Use of a Biodegradable, Load-Bearing Scaffold as a Carrier for Antibiotics in an Infected Open Fracture Model

Tien-Min G. Chu, D. Volgas, J. Stannard, 2010, Journal of orthopaedic trauma.

Contaminated open fracture and crush injury: a murine model

S. Gilbert, K. Waites, Justin Camara, 2015, Bone Research.

Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program

J. Dien Bard, K. Waites, T. Atkinson, 2019 .

Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program

J. Dien Bard, K. Waites, T. Atkinson, 2019 .

Deficient immune response to Mycoplasma pneumoniae in childhood asthma.

T. Atkinson, G. Cassell, L. Duffy, 2009, Allergy and asthma proceedings.